CompoAtlas

VITAMINITY DHT-Blocker Complex

Food supplement declared in France, declaration No 2023-5-1142, decision dated 25 May 2023

VITAMINITY DHT-Blocker Complex (VITAMINITY) is a food supplement declared in France. Status: declared in France, may be marketed. 6 rules of use apply to its ingredients (limits and warnings).

Brand
VITAMINITY
Food business operator placing the product on the market
VITAMINITY SRL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
2
Intended populations
Men
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, History of breast cancer, Taking away from meals, Children (under 12), Pregnant women, Infants (under 1 year), Taking medication, Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Hair and nails, Urinary system

Declaration 328508, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Serenoa repens (W.Bartram) SmallFruitExtrait sec hydroalcoolique640 mg
Prunus africana (Hook. f.) KalkmanEcorceExtrait sec hydroalcoolique250 mg
Urtica urens L.RacineExtrait sec hydroalcoolique250 mg
Camellia sinensis (L.) KuntzeFeuilleExtrait sec aqueux200 mg
Glycine max. (L.) Merr.GraineExtrait sec hydroalcoolique160 mg
Vitis vinifera L.GraineExtrait sec hydroalcoolique100 mg
Solanum lycopersicum L.FruitExtrait sec alcoolique50 mg
Haematococcus pluvialis FlotowThalleOléorésine et gomme-oléorésine2 mg

Other active ingredients

NamePer day
Phytostérolsnot declared

Additives

E420, E460, E553b, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Le produit n’est pas destiné aux personnes qui n’ont pas besoin de contrôler leur taux de cholestérol sanguin, les patients sous hypocholestérolémiants sont invités à ne consommer le produit que sous contrôle medicale. La consommation d’une quantité de stérols végétaux/stanols végétaux ajoutés supérieure à 3 grammes par jour doit être évitée. Le produit est déconseillé chez le femmes ayant des antécedents personnels ou familiaux de cancer du sein. Leproduit n’ est pas destinés à remplacer un mode de vie saine et il doit être utilisé dans le cadre d’une alimentation équilibrée et variée, comprenante une consommation régulière de fruits et légumes en vue de maintenir les niveaux de caroténoides. Il contient des allergènes potentiels de soja. Ne consommer pas 800 mg ou plus de épigallocatéchine-gallate (EGCG) par jour. Le produit ne doit pas être consommé si d’autres produits contenant du thé vert sont pris le même jour.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Serenoa repens (W.Bartram) Small
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Health Canada monograph dated 19 December 2025

  • Prunus africana (Hook. f.) Kalkman
    Read the warning, when it applies and the studies cited

    PYGEUM - PRUNUS AFRICANA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.

    Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 26 June 2026

  • Glycine max. (L.) Merr.
    Read the warning, when it applies and the studies cited
  • Haematococcus pluvialis Flotow
    Read the warning, when it applies and the studies cited

    Haematococcus pluvialis extract

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Eye strain, Eye fatigue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : VITAMINITY

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line